$HRGN
Harvard Apparatus Regenerative Technology Inc

2017 Q2 Form 10-Q Financial Statement

#000114420417043270 Filed on August 14, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $0.00 $28.00K
YoY Change -100.0% -61.64%
Cost Of Revenue $0.00 $44.00K
YoY Change -100.0% 18.92%
Gross Profit $0.00 -$16.00K
YoY Change -100.0% -144.44%
Gross Profit Margin -57.14%
Selling, General & Admin $1.039M $1.230M
YoY Change -15.53% -64.68%
% of Gross Profit
Research & Development $2.688M $1.680M
YoY Change 60.0% 60.0%
% of Gross Profit
Depreciation & Amortization $120.0K $110.0K
YoY Change 9.09% -8.33%
% of Gross Profit
Operating Expenses $3.727M $2.906M
YoY Change 28.25% -35.92%
Operating Profit -$3.727M -$2.922M
YoY Change 27.55% -35.05%
Interest Expense $120.0K $210.0K
YoY Change -42.86%
% of Operating Profit
Other Income/Expense, Net $124.0K $0.00
YoY Change
Pretax Income -$3.600M -$2.712M
YoY Change 32.74% -39.72%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.603M -$2.712M
YoY Change 32.85% -39.72%
Net Earnings / Revenue -9685.71%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.935M -$3.474M
COMMON SHARES
Basic Shares Outstanding 14.11M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.420M $8.100M
YoY Change -57.78% -20.04%
Cash & Equivalents $3.424M $8.100M
Short-Term Investments
Other Short-Term Assets $280.0K $160.0K
YoY Change 75.0% -5.88%
Inventory $50.00K
Prepaid Expenses
Receivables $0.00 $40.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.700M $8.340M
YoY Change -55.64% -21.17%
LONG-TERM ASSETS
Property, Plant & Equipment $960.0K $1.080M
YoY Change -11.11% -10.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $960.0K $1.080M
YoY Change -11.11% -10.0%
TOTAL ASSETS
Total Short-Term Assets $3.700M $8.340M
Total Long-Term Assets $960.0K $1.080M
Total Assets $4.660M $9.420M
YoY Change -50.53% -20.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $690.0K $600.0K
YoY Change 15.0% 87.5%
Accrued Expenses $1.160M $410.0K
YoY Change 182.93% 86.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.380M $1.940M
YoY Change 74.23% 228.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.380M $1.940M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.380M $1.940M
YoY Change 74.23% 228.81%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.280M $7.480M
YoY Change
Total Liabilities & Shareholders Equity $4.660M $9.420M
YoY Change -50.53% -20.04%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$3.603M -$2.712M
YoY Change 32.85% -39.72%
Depreciation, Depletion And Amortization $120.0K $110.0K
YoY Change 9.09% -8.33%
Cash From Operating Activities -$3.130M -$1.500M
YoY Change 108.67% -25.74%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$90.00K
YoY Change -77.78% 800.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$20.00K -$90.00K
YoY Change -77.78% 800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 4.850M
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.130M -1.500M
Cash From Investing Activities -20.00K -90.00K
Cash From Financing Activities 0.000 4.850M
Net Change In Cash -3.150M 3.260M
YoY Change -196.63% -260.59%
FREE CASH FLOW
Cash From Operating Activities -$3.130M -$1.500M
Capital Expenditures -$20.00K -$90.00K
Free Cash Flow -$3.110M -$1.410M
YoY Change 120.57% -29.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation
ShareBasedCompensation
397000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
665000 USD
us-gaap Depreciation
Depreciation
236000 USD
us-gaap Depreciation
Depreciation
224000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-275000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
230000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-46000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
108000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6193000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3984000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
125000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
217000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-125000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-217000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
483000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
644000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-42000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19000 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
0 USD
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
9000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
6801000 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
4496000 USD
bstg Fair Value Adjustment Of Warrants Gross
FairValueAdjustmentOfWarrantsGross
669000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2941000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7456000 USD
bstg Fair Value Adjustment Of Warrants Gross
FairValueAdjustmentOfWarrantsGross
-210000 USD
bstg Issuance Of Warrant In Connection With Issuance Of Common Stock
IssuanceOfWarrantInConnectionWithIssuanceOfCommonStock
3787000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2018000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2324000 USD
us-gaap Operating Expenses
OperatingExpenses
6775000 USD
bstg Issuance Of Warrant In Connection With Issuance Of Common Stock
IssuanceOfWarrantInConnectionWithIssuanceOfCommonStock
0 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0188 pure
CY2016 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.727 pure
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y7M6D
CY2016 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P4Y10M24D
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.51
CY2016Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.76
CY2017Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5991438 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1560284 shares
CY2017Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1525000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
3787000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
283000 USD
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
605000 USD
bstg Class Of Warrant Or Right Issuance Cost
ClassOfWarrantOrRightIssuanceCost
385000 USD
CY2013Q4 bstg Product Distribution Agreement Term
ProductDistributionAgreementTerm
P10Y
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37116570 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17108968 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37116570 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17108968 shares
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
28000 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
44000 USD
us-gaap Cost Of Revenue
CostOfRevenue
0 USD
us-gaap Cost Of Revenue
CostOfRevenue
44000 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
0 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-16000 USD
us-gaap Gross Profit
GrossProfit
0 USD
us-gaap Gross Profit
GrossProfit
-16000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4757000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3054000 USD
us-gaap Operating Expenses
OperatingExpenses
5378000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6775000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5394000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
669000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-210000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7444000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5184000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32143000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14822000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7444000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5184000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-228000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-174000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
349000 USD
bstg Fair Value Of Warrants Issued To Placement Agent
FairValueOfWarrantsIssuedToPlacementAgent
116000 USD
CY2016Q4 us-gaap Share Price
SharePrice
0.89
bstg Reclassified Additional Paid In Capital
ReclassifiedAdditionalPaidInCapital
-3150000 USD
CY2017Q2 bstg Warrants To Be Modifiednumber
WarrantsToBeModifiednumber
16568846 shares
CY2017Q2 bstg Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
3200000 USD
CY2017Q2 bstg Warrants To Be Remeasurednumber
WarrantsToBeRemeasurednumber
5991438 shares
CY2017Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2016Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
bstg Fair Value Of Warrant Liability Reclassified To Additional Paidin Capital
FairValueOfWarrantLiabilityReclassifiedToAdditionalPaidinCapital
3150000 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
124000 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
210000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-669000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
210000 USD
bstg Fair Value Of Warrants Issued To Placement Agent
FairValueOfWarrantsIssuedToPlacementAgent
0 USD
bstg Fair Value Of Warrant Liability Reclassified To Additional Paidin Capital
FairValueOfWarrantLiabilityReclassifiedToAdditionalPaidinCapital
0 USD
bstg Memorandum Of Understandingprivate Placementdescription
MemorandumOfUnderstandingprivatePlacementdescription
On June 26, 2017, the Company entered into a binding Memorandum of Understanding (the “MOU”) with First Pecos, LLC (“First Pecos”), pursuant to which the Company will issue to First Pecos in a private placement (the “Private Placement”) 9,700,000 shares of its common stock at a purchase price of $0.315 per share or, to the extent First Pecos, following the transaction, would own more than 19.9% of the Company’s common stock, shares of a new class of preferred stock of the Company (the “Preferred Stock”) with a per-share purchase price of $1,000.

Files In Submission

Name View Source Status
0001144204-17-043270-index-headers.html Edgar Link pending
0001144204-17-043270-index.html Edgar Link pending
0001144204-17-043270.txt Edgar Link pending
0001144204-17-043270-xbrl.zip Edgar Link pending
bstg-20170630.xml Edgar Link completed
bstg-20170630.xsd Edgar Link pending
bstg-20170630_cal.xml Edgar Link unprocessable
bstg-20170630_def.xml Edgar Link unprocessable
bstg-20170630_lab.xml Edgar Link unprocessable
bstg-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v472448_10q.htm Edgar Link pending
v472448_ex31-1.htm Edgar Link pending
v472448_ex31-2.htm Edgar Link pending
v472448_ex32-1.htm Edgar Link pending
v472448_ex32-2.htm Edgar Link pending